Recombinant Shigella flexneri serotype 5b Undecaprenyl-diphosphatase (uppP)

What is Undecaprenyl-diphosphatase (uppP) and what role does it play in Shigella flexneri?

Undecaprenyl-diphosphatase (uppP), also known as bacA, functions as an enzyme (EC 3.6.1.27) that catalyzes the dephosphorylation of undecaprenyl pyrophosphate to undecaprenyl phosphate. In Shigella flexneri serotype 5b, this enzyme is also referred to as the Bacitracin resistance protein, highlighting its role in antibiotic resistance . The protein is encoded by the uppP gene (synonymous with bacA) and serves as a critical component in peptidoglycan biosynthesis.

The primary function of uppP involves recycling the lipid carrier undecaprenyl phosphate, which is essential for transporting peptidoglycan precursors across the cytoplasmic membrane during cell wall synthesis. This process is particularly crucial for maintaining cell wall integrity during bacterial growth, division, and adaptation to environmental stresses. Without functional uppP, bacteria would face compromised cell wall synthesis, potentially affecting their survival and virulence.

Cell wall biosynthesis is especially important for pathogenic bacteria like S. flexneri during host colonization and infection, as it relates to bacterial survival in hostile host environments. While not directly studied in the context of virulence, the pathway uppP participates in represents a fundamental aspect of bacterial physiology that indirectly supports pathogenesis.

What are the structural characteristics of S. flexneri serotype 5b uppP protein?

According to available protein information, S. flexneri serotype 5b uppP consists of 273 amino acids with the sequence beginning with "MSDMHSLLIAAILGVVEGLTEFLPVS..." and continuing through the full sequence as documented . Analysis of this sequence reveals a predominantly hydrophobic protein consistent with its role as a membrane-associated enzyme.

The protein displays multiple predicted transmembrane domains, which is expected for an enzyme that interacts with membrane-embedded substrates like undecaprenyl pyrophosphate. The amino acid composition suggests a structure that positions the active site at the membrane interface to access its substrate efficiently.

The uppP protein belongs to a family of phosphatases that share a conserved catalytic mechanism. Though specific structural data such as crystal structures are not presented in the available research, homology modeling based on related bacterial phosphatases would likely reveal a conserved catalytic core with species-specific variations in peripheral regions.

The protein's structure must accommodate both membrane association and enzymatic function, allowing it to recognize its substrate and catalyze the hydrolysis of a pyrophosphate bond while integrated within the bacterial membrane environment.

How is recombinant uppP typically expressed and purified for research applications?

Recombinant S. flexneri serotype 5b uppP can be produced as a research-grade protein through several established molecular biology techniques. Based on standard protocols and product information, the typical expression and purification process involves :

• Gene cloning: The uppP (bacA) gene from S. flexneri serotype 5b is cloned into an appropriate expression vector, often with an affinity tag to facilitate purification.

• Expression system selection: While various expression systems exist, bacterial membrane proteins like uppP are commonly expressed in E. coli strains optimized for membrane protein production.

• Culture conditions: Expression typically occurs under controlled conditions with variables including temperature, media composition, and induction parameters optimized to balance protein yield and proper folding.

• Membrane fraction isolation: Since uppP is a membrane protein, isolation involves cell disruption followed by membrane fraction separation via ultracentrifugation.

• Solubilization: Detergents are used to extract the protein from the membrane environment while maintaining its native conformation.

• Affinity chromatography: Purification often employs tag-based methods, with the tag type determined during the production process to optimize purification efficiency .

• Additional purification steps: Size exclusion or ion exchange chromatography may be used to achieve higher purity.

For storage, the purified protein is typically maintained in a Tris-based buffer with 50% glycerol at -20°C, with extended storage recommended at -20°C or -80°C . To preserve activity, repeated freezing and thawing should be avoided, and working aliquots can be kept at 4°C for up to one week.

How does uppP contribute to Shigella flexneri virulence and pathogenesis?

While the direct relationship between uppP and S. flexneri virulence has not been extensively characterized in the available research, several indirect connections can be inferred based on our understanding of bacterial pathogenesis mechanisms.

Cell wall integrity, which uppP helps maintain through its role in peptidoglycan biosynthesis, is fundamental to bacterial survival during infection. Research has demonstrated that multiple signaling pathways affect S. flexneri pathogenesis, and disruption of these pathways can diminish expression of key virulence genes . For instance, the stringent response alarmone (p)ppGpp has been shown to be required for S. flexneri virulence, with its disruption reducing bacterial invasion and intercellular spread .

The connections between uppP and virulence might include:

• Stress adaptation: During host colonization, S. flexneri encounters various stresses including nutrient limitation, pH changes, and antimicrobial compounds. Proper cell wall maintenance through uppP activity could be critical for stress resistance.

• Maintaining cellular integrity during invasion: S. flexneri invades intestinal epithelial cells, a process that subjects the bacterium to mechanical and environmental stresses requiring robust cell wall structure.

• Supporting intercellular spread: Once inside host cells, S. flexneri spreads to adjacent cells, a process that depends on the IcsA protein . Cell wall integrity maintained by uppP activity may support this process.

Experimental approaches to further investigate these connections could include creating conditional uppP mutants and assessing their virulence in cell culture models, particularly examining invasion efficiency and intercellular spread capabilities.

What methodological challenges exist in studying membrane-bound enzymes like uppP?

Investigating membrane proteins such as uppP presents several significant methodological challenges that researchers must address through specialized techniques:

• Expression and purification difficulties:

  • Membrane proteins often express poorly in heterologous systems

  • Proper folding and membrane insertion requires specific conditions

  • Solubilization requires detergents that must maintain native structure

  • Purification yields are typically lower than for soluble proteins

• Structural analysis limitations:

  • Crystallization for X-ray diffraction is challenging due to hydrophobic surfaces

  • Detergent micelles can interfere with crystal contacts

  • NMR studies are complicated by size constraints and membrane environment requirements

  • Cryo-EM may require specialized grid preparations for membrane proteins

• Enzymatic assay complexities:

  • The hydrophobic substrate (undecaprenyl pyrophosphate) requires proper solubilization

  • Maintaining enzyme activity in detergent environments is challenging

  • Reproducing the native membrane environment for optimal activity

  • Distinguishing specific activity from background phosphatase activity

• In vivo functional studies:

  • Creating clean knockouts may affect membrane integrity

  • Complementation studies require proper membrane targeting

  • Distinguishing direct from indirect effects on cellular physiology

To address these challenges, researchers typically employ multiple complementary approaches, including:

• Nanodiscs or liposome reconstitution to provide native-like membrane environments

• Fusion partners to enhance expression and solubility

• Multiple detergent screening to identify optimal conditions

• Combined structural methods (computational modeling with experimental validation)

These methodological considerations are essential when designing experiments to characterize uppP function, regulation, and potential as a therapeutic target.

How can recombinant uppP be utilized in antimicrobial drug discovery?

Recombinant S. flexneri serotype 5b uppP represents a valuable tool for antimicrobial drug discovery, particularly given the rising antibiotic resistance in Shigella species . Several approaches leverage recombinant uppP in drug development:

• Target-based screening:

  • High-throughput enzymatic assays using purified recombinant uppP

  • Screening of chemical libraries for inhibitors of phosphatase activity

  • Structure-activity relationship studies to optimize lead compounds

  • Counterscreening against human phosphatases to ensure selectivity

• Structural biology approaches:

  • Using purified recombinant protein for structural determination

  • Structure-based drug design targeting active site or allosteric sites

  • Fragment-based screening to identify chemical starting points

• Cellular validation systems:

  • Testing compounds in bacterial strains with modified uppP expression

  • Complementation studies with recombinant uppP to confirm target specificity

  • Measuring effects on peptidoglycan synthesis and cell wall integrity

• Resistance mechanism studies:

  • Investigating potential resistance mechanisms using recombinant protein

  • Engineering mutations observed in resistant strains

  • Biochemical characterization of variant proteins

The potential of this approach is supported by the understanding that cell wall biosynthesis remains a validated antibacterial target, with several existing antibiotics targeting various steps in this pathway. Bacitracin itself targets the undecaprenyl pyrophosphate recycling pathway, though not directly through uppP inhibition .

The availability of purified recombinant uppP allows for detailed biochemical characterization that can inform rational drug design strategies, potentially leading to novel therapeutics against multidrug-resistant Shigella infections.

What are the optimal conditions for enzymatic assays measuring uppP activity?

Developing robust enzymatic assays for uppP activity requires careful optimization of multiple parameters to ensure reliable and reproducible results. The following methodological considerations are essential:

• Substrate preparation:

  • Undecaprenyl pyrophosphate is highly hydrophobic and requires appropriate solubilization

  • Options include detergent micelles (Triton X-100, DDM), mixed micelles with phospholipids, or incorporation into liposomes

  • Commercial substrates may be used, but concentration determination requires specific methods due to the absence of chromophores

• Reaction buffer optimization:

  • pH optimization typically in the range of 7.0-8.0

  • Divalent cation requirements (Mg²⁺, Mn²⁺) at concentrations of 1-10 mM

  • Ionic strength adjustment to maintain enzyme stability

  • Detergent concentration above critical micelle concentration but below inhibitory levels

• Detection methods:

  • Colorimetric detection of released inorganic phosphate (malachite green, molybdate blue)

  • HPLC separation of substrate and product

  • Mass spectrometry for direct product detection

  • Coupled enzyme assays linking phosphate release to spectrophotometric changes

• Assay validation parameters:

  • Linear range determination with respect to time and enzyme concentration

  • Controls for non-enzymatic hydrolysis

  • Specificity controls with known phosphatase inhibitors

  • Reproducibility assessment across multiple enzyme preparations

An optimized protocol might include:

Kinetic parameters determined through such optimized assays provide valuable information about enzyme efficiency and potential inhibitor mechanisms.

How can protein-protein interactions involving uppP be effectively studied?

Understanding uppP's interactions with other proteins provides insights into its regulation and broader role in cellular physiology. Several complementary approaches are effective for studying these interactions:

• Co-immunoprecipitation strategies:

  • Antibody-based pulldown of tagged recombinant uppP

  • Crosslinking prior to solubilization to capture transient interactions

  • Gentle detergent conditions to maintain interaction integrity

  • Mass spectrometry identification of co-precipitated proteins

• Bacterial two-hybrid systems:

  • BACTH (Bacterial Adenylate Cyclase Two-Hybrid) adapted for membrane proteins

  • Split-ubiquitin systems for membrane protein interactions

  • Quantification through reporter gene expression

  • Controls for membrane localization and protein expression

• Proximity-based approaches:

  • BioID or TurboID fusions to uppP expressed in S. flexneri

  • In vivo biotinylation of proximal proteins

  • Streptavidin pulldown and mass spectrometry identification

  • Differentiates direct and indirect interactors within native context

• Biophysical interaction characterization:

  • Surface Plasmon Resonance with detergent-solubilized or nanodisc-reconstituted uppP

  • Microscale Thermophoresis for interaction affinity determination

  • Analytical ultracentrifugation to detect complex formation

  • Fluorescence-based techniques (FRET, BRET) for in vitro or in vivo studies

• Crosslinking Mass Spectrometry:

  • Chemical crosslinking to stabilize interactions

  • Digestion and identification of crosslinked peptides

  • Provides structural information about interaction interfaces

  • Compatible with detergent-solubilized membrane proteins

These approaches can reveal interaction partners involved in peptidoglycan synthesis, membrane organization, or regulatory pathways. Similar methodologies have been successfully applied to study virulence-associated proteins in S. flexneri, as evidenced by research on pathogenesis factors .

A typical workflow might begin with proximity labeling to identify potential interactors, followed by validation through co-immunoprecipitation and characterization of direct interactions using purified components. Functional validation through genetic approaches would complete the investigation.

What expression systems are most effective for producing functional recombinant uppP protein?

Producing functional recombinant uppP presents challenges common to membrane proteins but can be achieved through careful selection and optimization of expression systems:

• Bacterial expression systems:

  • E. coli BL21(DE3) derivatives specialized for membrane proteins:

    • C41(DE3) or C43(DE3) strains for reduced toxicity

    • Lemo21(DE3) for tunable expression control

  • Expression vectors with moderate promoter strength:

    • pET series with T7 promoter and lac operator

    • Arabinose-inducible systems for tight regulation

  • Fusion partners to enhance solubility and detection:

    • N-terminal or C-terminal His-tags for purification

    • MBP or SUMO fusions for solubility enhancement

    • GFP fusions to monitor folding and membrane insertion

• Optimization parameters:

  • Induction conditions:

    • Lower temperatures (16-25°C) to slow production rate

    • Reduced inducer concentrations (0.1-0.5 mM IPTG)

    • Extended expression periods (overnight)

  • Media composition:

    • Rich media (2xYT, TB) for high cell density

    • Supplementation with glycerol (0.5-1%) as membrane stabilizer

    • Defined media for controlled expression and isotopic labeling

• Alternative expression systems:

  • Cell-free expression systems:

    • Provides direct access to the protein without extraction

    • Allows addition of detergents or lipids during synthesis

    • Reduced issues with toxicity or inclusion body formation

  • Yeast systems (Pichia pastoris):

    • Eukaryotic processing with prokaryotic simplicity

    • Strong induction with methanol

    • Integration into genome for stable expression

• Extraction and purification considerations:

  • Membrane isolation through differential centrifugation

  • Detergent selection critical for functional extraction:

    • DDM (n-Dodecyl β-D-maltoside) often effective

    • LMNG (Lauryl Maltose Neopentyl Glycol) for stability

  • Purification typically through affinity chromatography

  • Storage in 50% glycerol at -20°C as recommended for the recombinant protein

Expression yield and protein quality should be validated through activity assays and structural integrity assessment (circular dichroism, thermal shift assays). The optimal expression system may vary depending on the specific requirements of the downstream applications.

How might CRISPR-Cas9 technologies advance functional studies of uppP in Shigella pathogenesis?

CRISPR-Cas9 technology offers powerful approaches for investigating uppP function in S. flexneri, particularly in the context of pathogenesis. These advanced genetic tools enable:

• Precise genetic manipulation:

  • Generation of clean knockout strains to study essentiality

  • Introduction of point mutations to identify critical residues

  • Creation of conditional expression systems through promoter replacement

  • Precise tagging at endogenous loci for localization studies

• High-throughput functional genomics:

  • CRISPR interference (CRISPRi) for tunable gene repression

  • CRISPR activation (CRISPRa) for enhanced expression

  • Pooled CRISPR screens to identify genetic interactions

  • Systematic mutagenesis to create comprehensive variant libraries

• Infection model applications:

  • Real-time tracking of uppP expression during infection

  • CRISPR-mediated regulation of expression timing

  • Investigation of uppP requirement at different infection stages

• Methodological approach comparison:

Research approaches similar to those used in studying virulence genes, such as the methodology applied to investigate the role of (p)ppGpp in S. flexneri pathogenesis , could be adapted for uppP analysis. For example, CRISPR-engineered strains with modified uppP expression could be tested for their ability to form plaques in epithelial cell monolayers, similar to the examination of relA spoT mutants .

These genomic technologies would significantly advance our understanding of how uppP contributes to S. flexneri's adaptation to the intracellular environment, potentially revealing new strategies for antimicrobial development.

What is the potential for uppP inhibitors as novel therapeutic agents against Shigella infections?

The emergence of antimicrobial resistance in Shigella species creates an urgent need for novel therapeutic targets . UppP represents a promising candidate for inhibitor development based on several factors:

• Target validation considerations:

  • Essential role in peptidoglycan synthesis pathway

  • No human homolog, reducing off-target effects

  • Existing precedent of targeting this pathway (bacitracin)

  • Potential to disrupt bacterial cell wall integrity

• Inhibitor discovery strategies:

  • Structure-based virtual screening using homology models

  • Fragment-based screening against purified recombinant protein

  • High-throughput enzymatic assays with phosphatase activity readout

  • Whole-cell phenotypic screens with target validation

  • Repurposing screens of approved drug libraries

• Potential advantages of uppP inhibitors:

  • Novel mechanism of action to overcome existing resistance

  • Potential narrow-spectrum activity against specific pathogens

  • Opportunity for combination therapy with existing antibiotics

  • Possible anti-virulence effects beyond growth inhibition

• Challenges and considerations:

  • Membrane-embedded target requiring specific physicochemical properties

  • Penetration of Gram-negative outer membrane

  • Potential for resistance development

  • Selectivity against commensal bacteria

• Development pipeline prospects:

  • Lead identification through recombinant protein screening

  • Medicinal chemistry optimization of physicochemical properties

  • In vitro and cellular validation studies

  • Animal model efficacy testing

  • Resistance potential assessment

The availability of recombinant uppP protein facilitates initial screening efforts, while research on S. flexneri pathogenesis mechanisms provides context for understanding the therapeutic implications of targeting this enzyme. Successful development of uppP inhibitors could address the significant global health burden of Shigella infections, particularly in low- and middle-income countries where these infections are most prevalent .